戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 1, 4-naphthoquinones and 2,3-bis(substituted phenoxy)-1, 4-naphthoquinones may suggest an approach fo
2 1a, N2O2(red) = N,N'-bis(3,5-di-tert-butyl-2-phenoxy)-1,2-phenylenediamide, L = THF) was explored wit
3 ally triggered release and an adamantylidene-phenoxy-1,2-dioxetane chemiluminophore payload.
4 e chemiluminescent light-emission pathway of phenoxy-1,2-dioxetane luminophores attracts growing inte
5 strain cyclic olefin monomer, 1,3-dimethyl-2-phenoxy-1,3,4,7-tetrahydro-1,3,2-diazaphosphepine 2-oxid
6 ibrary of 2-phenoxy-1,4-naphthoquinone and 2-phenoxy-1,4-anthraquinone derivatives was initially deve
7 ure-activity relationships for a series of 3-phenoxy-1,4-diarylazetidin-2-ones were investigated, lea
8                         A small library of 2-phenoxy-1,4-naphthoquinone and 2-phenoxy-1,4-anthraquino
9 luding trans-4-(3-hydroxy-4-methoxyphenyl)-3-phenoxy-1-(3,4,5-trimethoxyphenyl)azetidin- 2-one (78b)
10 78b) and trans-4-(3-amino-4-methoxyphenyl)-3-phenoxy-1-(3,4,5-trimethoxyphenyl)azetidin-2- one (90b).
11                             For the simple 2-phenoxy-1-phenylethane or its alcohol congener, 2-phenox
12 he conversion of the lignin model compound 2-phenoxy-1-phenylethanol shifts from phenol and acetophen
13 xy-1-phenylethane or its alcohol congener, 2-phenoxy-1-phenylethanol, the benzylic site is activated
14 l and acetophenone on bare ZIS to H(2) and 2-phenoxy-1-phenylethanone on the ZIS|NiP system (5 sun).
15                                 The 15(R)-16-phenoxy-17,18, 19,20-tetranor-LXA4 methyl ester (15-epi-
16  aspirin triggered 15-epi-LXA4, and 15(S)-16-phenoxy-17,18,19,20-tetranor-LXA4 methyl ester (16-pheno
17 alpha(1E,3S*), 4alpha]-7-[3[(3-hydroxy-4-(4'-phenoxy)-1butenyl)-7-oxabicycl o-[2.2.1]heptan-2-yl]-5-h
18 fonyl) benzamide), 931126 (2; 4-oxo-4-{2-[(5-phenoxy-1H-indol-2-yl)carbonyl]hydrazino}-N-(4-phenylbut
19 oles to synthesize 2-phenoxy-3H-indole and 2-phenoxy-1H-indole derivatives in the presence of diaryl
20 arried out, leading to the preparation of (4-phenoxy)-(2-n-pentylcarbonyl)-phenoxyethyl selenocyanate
21 is, and structure-activity relationship of 1-phenoxy-2-aminoindanes as inhibitors of the Na(+)/H(+) e
22                                   Aligning 1-phenoxy-2-aminoindanes onto the X-ray structure of 13d t
23 , 4-(4-methylphenoxy)-2-butyn-1-amine, and 4-phenoxy-2-butyn-1-amine.
24 diphenoxy-2-lambda(5)-phosphaquinolines or 2-phenoxy-2-lambda(5)-phosphaquinolin-2-ones under transit
25        Two diastereomeric 5-bromo-4-phenyl-2-phenoxy-2-oxo-1,3,2-dioxophosphepanes have been synthesi
26  used to study the contraction of 4-phenyl-2-phenoxy-2-oxo-1,3,2-dioxophosphorinan-5-yl radicals.
27 nated aromatic species (phenoxyethanol and 1-phenoxy-2-propanol), two esters (butyl butyrate and buty
28 [(3,5-disubstituted anilino)carbonyl]methyl] phenoxy] -2-methylproprionic acid derivative (RSR13), du
29 en ([6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene hydrochl
30 e ([6-hydroxy-3-[4-[2-(1-piperidinyl)-ethoxy]phenoxy]-2-(4-methoxyphenyl)]be nzo[b]thiophene) is a se
31 1-[4-[[(3, 5-dimethylanilino)carbonyl]methyl]phenoxy]-2-methylcyclopentane carbox ylic acid (11), exh
32 f 2,4-[[(3,5-dimethylanilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid (RSR13, efaproxiral) 100
33 2-[4-[[(3,5-dimethylanilino) carbonyl]methyl]phenoxy]-2-methylpropionic acid, a synthetic allosteric
34 (2-[4-[[3,5-dimethylanilino) carbonyl]methyl]phenoxy]-2-methylproprionic acid) intravenously before o
35 [4-(1-methyl-4-trifluoromethyl -2-imidazolyl)phenoxy]-2-propanol dihydrochloride (CGP-20712A) prevent
36 [4-(1-methyl-4-trifluoromethy l-2-imidazolyl)phenoxy]-2-propanol], which showed no agonistic activity
37 [4-(1-methyl-4-trifluormet hyl-2-imidazolyl)-phenoxy]-2-propanolmethanesulfonate (CGP20712A), betaxol
38 [4-(1-methyl-4-trifluormet hyl-2-imidazolyl)-phenoxy]-2-propanolmethanesulphonate (CGP 20712A) and at
39 methy l)phenyl]-1,3-thiazol-5-yl}methyl)thio]phenoxy}-2-methylpropanoic acid (1), a potent PPARpan ag
40                                A series of 2-phenoxy-3-phenylpropanoic acids has been prepared which
41 8 (N-((2-(methoxy-(11)C)-phenyl)methyl)-N-(6-phenoxy-3-pyridinyl)acetamide) binds to the 18-kDa trans
42 8 (N-((2-(methoxy-(11)C)-phenyl)methyl)-N-(6-phenoxy-3-pyridinyl)acetamide) PET scans were acquired w
43 udies on the acyclic analog 8 provided the 2-phenoxy-3-pyridylurea analog 18 with improved antiischem
44  pulcherosine (5-[4"-(2-carboxy-2-aminoethyl)phenoxy]3, 3'-dityrosine) by high resolution NMR spectro
45 e O-arylation of 2-oxindoles to synthesize 2-phenoxy-3H-indole and 2-phenoxy-1H-indole derivatives in
46 covery of (R)-4-[2-cyano-5-(3-pyridylmethoxy)phenoxy]-4-(2-methylphenyl)b utanoi c acid (12m).
47  derivatives of 3, 2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine (4) and 2-(2-(dimethylaminome
48 [methyl-(11)C]N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine) is a recently developed radiolig
49 [methyl-(11)C]N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine)) ( approximately 1.2).
50 ific structural modifications to the benzoyl-phenoxy-acetamide (BPA) structure present in a common li
51 carboxylic group readily splits off from the phenoxy-acetate radical anion to give carbon dioxide.
52 hylphenyl)-1,3-thiazol-5-yl)-methylsulfany l)phenoxy-acetic acid (GW501516)] and RA.
53 (3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy] acetic acid sodium hydrate) or SR 59,230 (3-(2-
54 hyl)phenyl]-1,3-thiazol-5-yl]methylsu lfanyl]phenoxy]acetic acid), significantly reduced ischemia-ind
55 methyl-thiazol-5-ylmethylsulfanyl]-2-m ethyl-phenoxy}-acetic acid (GW0742)-induced up-regulation of A
56                                              Phenoxy acid herbicides are important groundwater contam
57 als of environmental concern--including some phenoxy acid herbicides, organophosphorus insecticides,
58 ticides (i.e. organophosphorus insecticides, phenoxy-acid herbicides, and triazine herbicide) to inhi
59 segment) and 1,10-bis[p-(benzylammoniomethyl)phenoxy]alkane bis(hexafluorophosphate)s (AyA, y = numbe
60 ated Wang linker derivative ((4-bromomethyl)-phenoxy-allyl acetate) (6) to give after ester hydrolysi
61 noic acid (rac-9), is formed by closure of a phenoxy-allyloxy intermediate 17 collapsing to a cyclopr
62 mpound bearing a N,N-bis(3,5-di-tert-butyl-2-phenoxy)amide ligand is reported.
63 cysteines of peptides couple covalently with phenoxy amino squarate moieties presented on self-assemb
64 ch tautomerism, were equal in potency to the phenoxy analogues and demonstrated selectivity for the l
65                        A series of amino and phenoxy analogues have been synthesized, and although th
66 and that a trans configuration between the 3-phenoxy and 4-phenyl rings is generally optimal.
67 supported by terphenyl ligands appended with phenoxy and imine donors were synthesized.
68 c) ketones within the HS to form initially a phenoxy and ketyl radical.
69 roduct consistent with the cross-reaction of phenoxy and naphthoxy radicals.
70 ubsequent SAR studies have revealed that the phenoxy and phenylsulfanyl analogues of 6c, 3-(1-carboxy
71 his system hydrogenates functionalized alpha-phenoxy and related amides at room temperature under 4 a
72 g., methyl, hydroxy, amino, methoxy, phenyl, phenoxy) and electron withdrawing (e.g., fluorine, chlor
73  results suggested the presence of methoxyl, phenoxy, and substituted phenoxy radicals as precursors
74  efficient regiospecific 7-mono- and 7,12-di-phenoxy bay substitution at the "imide-activated" 7- and
75 2-(3,5-dimethylphenyl)pyrrolidin-1-yl)methyl)phenoxy)benzami de], JSPA071B [(S)-3-fluoro-4-(4-((2-(3,
76 4-((2-(3-fluorophenyl)pyrrolidin-1-yl)methyl)phenoxy)benzamide], and naloxone.
77 ne ((+/-)-N-methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride; FLX) are frequ
78 -((2-hydroxyethoxy)methyl)-5-(3-(substituted-phenoxy)benzyl)uracils as inhibitors of murine liver uri
79 etains both fluorine atoms and provides beta-phenoxy-beta,beta-difluorobenzyl alcohols.
80 2-hydroxy-3-propyl-4-[4-[4-(2H-tetrazol-5-yl)phenoxy]butoxy]phenyl) ethanone (4).
81 tigated; homologues 4-[4-(3-(trifluoromethyl)phenoxy)butyl]-1H-imidazole and 4-[2-(3-(trifluoromethyl
82 4-[4-[[(1,1-Dimethylethyl)-oxidoimino]methyl]phenoxy]butyl]triphenylphosp honium bromide (MitoPBN) pr
83 tivation of a pyrone C-Br or C-Cl bond and a phenoxy C-H bond.
84 The most potent member of the series, the 7'-phenoxy compound 14, binds to the delta site with a Ki o
85                             In addition, the phenoxy compounds, which were not inhibitors of NQO1 enz
86  methoxy, ethyl, ethoxy, isopropoxy, phenyl, phenoxy, cyclohexyl, and cyclohexoxy substituents.
87 [1-[4-(((3,5-dimethylanilino)carbonyl)methyl)phenoxy]cyclopentanecarboxyli c acid] with different D-
88 ing sites in 1,10-bis[p-(benzylammoniomethyl)phenoxy]decane bis(hexafluorophosphate) (A10A) were show
89                      Both inhibitors and the phenoxy derivative of 3 have activity against P. aerugin
90                               All of the new phenoxy derivatives have potent in vitro antimalarial ac
91           Hence, benzyloxy, benzylamino, and phenoxy derivatives of 5-phenyl-3-isoxazolecarboxylic ac
92                    A series of benzyloxy and phenoxy derivatives of the adenosine receptor agonists N
93  value of 1.1 for the unsubstituted adduct 8-phenoxy-dG (Ph-O-dG).
94 none trigger moiety covalently tethered to a phenoxy-dioxetane moiety through a para-aminobenzyl alco
95     A simple and regioselective synthesis of phenoxy esters and phenylthio esters is reported.
96 he ability of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, an AEBS-specific ligand, to comp
97 with acetoxymethyl ester of 1,2-bis (2-amino-phenoxy) ethane N:, N:, N:, N:-tetra-acetic acid (BAPTA-
98 revented by calcium chelator 1,2-bis(2-amino phenoxy)ethane-N,N,N', N'-tetraacetic acid.
99 ne-permeant calcium chelator 1,2-bis(2-amino phenoxy)ethane-N,N,N',N'-tetraacetic acid-tetrakis (acet
100 ol (p262-NP), 2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]ethanol (OP1EO) and endosulfan.
101 reas the O isostere 4-[2-(3-(trifluoromethyl)phenoxy)ethyl]-1H-imidazole is an antagonist as is the S
102 rmamidine) and B-TPMF (N-{7-[1-(4-tert-butyl-phenoxy)ethyl]-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl}-N'-
103 thanol,alpha-[1-[2,6-dimethoxy-4-(2-propenyl)phenoxy]ethyl]- acetate, (5) licarin C; benzofuran,2,3-d
104 ol; alpha-[1-[2,6-dimethoxy-4-(2-propen-1-yl)phenoxy]ethyl]-3,4-dimethoxy-1-acetate, (3) odoratisol A
105  N-[2-[5-methyl-3-(2-chlorophenylsulfonyloxy)phenoxy]ethyl]-N- methyl-4 -aminopyridine (1), has been
106  and CGP-20712 [1-[2-((3-carbamoyl-4-hydroxy)phenoxy)ethylamino]-3-[4-(1-methyl-4-trifluoromethy l-2-
107 ptor antagonist 1-[2-((3-Carbamoyl-4-hydroxy)phenoxy)ethylamino]-3-[4-(1-methyl-4-trifluoromethyl -2-
108 compounds with carbonyl substitutions of the phenoxy group (ester, amide, or ketone moieties) demonst
109 stabilization mechanisms associated with its phenoxy group located in the membrane hydrocarbon core.
110                   The para-position of the 4-phenoxy group of the thieno[2,3-c]pyridine lead is found
111 lubilizing group at the para-position of the phenoxy group to increase the aqueous solubility of this
112 assay clustered among compounds in which the phenoxy group was substituted at the 3, 4, or 5 position
113  of the 1,7 bromine atoms in the bay area by phenoxy groups, which is a generally applied reaction fo
114 eplacing all but one phenylseleno group with phenoxy groups.
115 formation is accompanied by the loss of both phenoxy groups.
116 l-5-[7-[4-[(4S)-4-methyl-1,3-oxazolidin-2-yl]phenoxy]heptyl]-1,2-oxazole (W84) and gallamine.
117 uminum phosphide and ethylene dibromide; the phenoxy herbicide (2,4,5-trichlorophenoxy)acetic acid (2
118                                    Likewise, phenoxy herbicides may have adverse metabolic effects in
119 -(mercaptoethyl)-6-(3-(2-(methylamino)propyl)phenoxy)hexanamide [3, (+)-METH HSMO9] and its use to pr
120 ride (6FDA) with bis[omega-[4-(4-cyanophenyl)phenoxy]hexyl] 4,4'-diamino-2,2'-biphenyldicarboxylate (
121                                        Azole phenoxy hydroxyureas are a new class of 5-lipoxygenase (
122 Ti(CH2SiMe3)2Me and (FI)Ti(CH2CMe3)2Me (FI = phenoxy-imine), have been synthesized and structurally c
123  same media lead to the conclusions that (1) phenoxy is less reactive overall than 1-naphthoxy toward
124 les and o-QM precursors tethered by a simple phenoxy linker and furnishes cycloadducts with a promine
125 examined the effects of 15-epi-16-(p-fluoro)-phenoxy-lipoxin A(4) methyl ester, an aspirin-triggered
126 table analog of ATL, 15-epi-16-(para-fluoro)-phenoxy-lipoxin A4 analog (ATLa), inhibits neutrophil re
127                          15-epi-16-(p-fluoro)phenoxy-LXA(4) (ATLa(1)) blocked the secretion of TNF-al
128  15-epi-LXA(4), a new 15-epi-16-(p-trifluoro)phenoxy-LXA(4) analog (ATLa(2)), as well as LXB(4), and
129 tion of LXA(4) analog (15-epi-16-para-fluoro-phenoxy-LXA(4), 10 microg/day) significantly reduced the
130 y-LXA4 approximately 5(S)-methyl-LXB4 >/= 16-phenoxy-LXA4 > 5(R)-methyl-LXB4.
131 ] and the omega end [15-epi-16-(para-fluoro)-phenoxy-LXA4 (ATLa2)] were recoverable to approximately
132                          Neither LXA4 nor 16-phenoxy-LXA4 affected monocyte-mediated cytotoxicity.
133 rder of 15(R/S)-methyl-LXA4 > 16-para-fluoro-phenoxy-LXA4 approximately 5(S)-methyl-LXB4 >/= 16-pheno
134                     15R/S-methyl-LXA4 and 16-phenoxy-LXA4 each attenuated (IC50 approximately 10 nM)
135 d 15-epi-LXA4 were equal in activity, and 16-phenoxy-LXA4 was more potent than native LXA4.
136              Both 15(R/S)-methyl-LXA4 and 16-phenoxy-LXA4 were approximately 1 log molar more potent
137 y-17,18,19,20-tetranor-LXA4 methyl ester (16-phenoxy-LXA4) were each as potent as equimolar applicati
138  19,20-tetranor-LXA4 methyl ester (15-epi-16-phenoxy-LXA4), an analogue of aspirin triggered 15-epi-L
139  0.05) cells/100 micron length of venule (16-phenoxy-LXA4-Me, 15-cyclohexyl-LXA4-Me, and 15-R/S- meth
140 t stable lipoxin A4 (LXA4) analogs (i.e., 16-phenoxy-LXA4-Me, 15-cyclohexyl-LXA4-Me, and 15-R/S-methy
141 as (3S,4R)-3 contains a [3,4-(methylenedioxy)phenoxy]methyl group.
142 )-4-(4-Fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl] piperidine [(3S,9R)-3, paroxetine] is a
143 fluoroethyl)-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]-3 ,5-dimethyl-pyridine) and studied test
144 f 3-(4-fluorophenyl)-2-[[3,4-(methylenedioxy)phenoxy]methyl]nortropane+ ++ (4).
145 ,5-dimethyl-4-(4'-hydroxy-3'-isopropylbenzyl)phenoxy)methylphosphonic acid (MB07344), which distribut
146 IPY dyes bearing alkoxy or nonfunctionalized phenoxy moieties are characterized by a highly efficient
147 hibitors and selected 2-(tetrahydroindazolyl)phenoxy-N-(thiadiazolyl)propanamide 2 (TIPTP, M.W. 437.4
148 3-(dimethylamino)propoxy)benzo[d]oxazol-2-yl)phenoxy]-N,N-dimethylpropa n-1-amine} and E6446 {6-[3-(p
149 agonist naltrindole (1) possessing a phenyl, phenoxy, or benzyloxy group at the 4'-, 5'-, 6'-, or - 7
150 ation of an alpha-chloroaldehyde or an alpha-phenoxy- or alpha-acetoxy ketone with a substituted benz
151 een an acetate methyl group deuteron and the phenoxy oxygen of YZ*.
152       Topical application with the 15-epi-16-phenoxy-para-fluoro-LXA(4) stable analog (ATLa) dramatic
153 ed of three covalently linked 1,6,7,12-tetra(phenoxy)perylene-3,4:9,10-bis(dicarboximide) (PDI) units
154 polycrystalline thin films of 1,6,7,12-tetra(phenoxy)perylene-3,4:9,10-bis(dicarboximide) having eith
155  gamma/delta agonist (R)-3-{4-[3-(4-chloro-2-phenoxy-phenoxy)-butoxy]-2-ethyl-phenyl}-propionic acid
156   5-(1H-Indol-5-yl)-3-(4-(4-(trifluoromethyl)phenoxy)phenyl)-1,2,4-oxadiazole (antibiotic 75b) was ef
157  (HA 966, 15 mg/kg), 7-chloro-4-hydroxy-3-(3-phenoxy)phenyl-2(H)-quinolinone) (L-701,324, 40 mg/kg),
158  methyl 2-(4-{4-[(2-thiiranylpropyl)sulfonyl]phenoxy}phenyl)acetate (3) and 2-(4-{4-[(2-thiiranylprop
159 (3) and 2-(4-{4-[(2-thiiranylpropyl)sulfonyl]phenoxy}phenyl)acetic acid (4), and show that compound 3
160 1,2,4]triazine (RTI-4229-707), 5-methyl-3-(4-phenoxy-phenylethynyl-[1,2,4]triazine (RTI-4229-766), an
161 paB ligand, and by 4-[4-(methanesulfonamido) phenoxy] phenylsulfonyl methylthiirane, an MT1-MMP inhib
162 metabolism identified 5'-methyl [(S)-hydroxy(phenoxy)phosphoryl]-l-alaninate in combination with 2',3
163  (4-methyl-2,6-bis((prop-2-yn-1-yloxy)methyl)phenoxy) phthalocyaninato zinc(II) (Pc) bearing sixteen
164 he structural modification of the tert-butyl phenoxy portion of lead compound 1 and the subsequent di
165 eners were a l-aspartic acid diisoamyl ester phenoxy prodrug and a l-phenylalanine propyl ester phosp
166           The ortho-alkylated derivatives of phenoxy products possessing the ester functionality unde
167 xo-4,5-dihydro-1H-1,2,4-triazol-3- yl]propyl}phenoxy)propanoic acid (LY518674).
168 ng amino acid, benzyl carboxylic acid, and 2-phenoxy propionic acid, undergo oxidative decarboxylatio
169           2-(4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469) is among the most highly
170 he 7-position of a 2-(4-[(2-quinoxalinyl)oxy]phenoxy)propionic acid, generated the most highly and br
171 sult, (2R)-7-(3-[2-chloro-4-(4-fluorophenoxy)phenoxy]propoxy)-2-ethylchromane-2- carboxylic acid (48)
172 -2-amine (R-like)] related to riluzole and a phenoxy-propranol-amine moiety [(RS)-1-(3,4-difluorophen
173 to the local anesthetic receptor through its phenoxy-propranol-amine moiety, with consequent use-depe
174 n of N-(3-(4-(2-(4-hydroxyphenyl)propan-2-yl)phenoxy)propyl) 3-(5-hydroxy-1,4-dihydro-1,4-dioxonaphth
175 em seems optimal and an N(2)-(3-(substituted-phenoxy)propyl) moiety results in high affinity, (c) tha
176  = 0.54 mg/kg) and 4-[3-[4-(trifluoromethyl)-phenoxy]propyl]-1H-imidazole (10c, UCL 1409; Ki = 14 nM,
177  SC-57461A (8d, 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid) are described.
178 mor effect of a novel 30-compound library of phenoxy pyridine and phenyl sulfanyl pyridine derivative
179 -(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)-pyridine-2-carboxyllic acid methyamide-4-methyl
180 butyl-[1,4]diazepane-1-carbonyl)-4-(3-fluoro-phenoxy)-pyrrolidin-1-y l]-ethanone, a hydroxyproline-ba
181 ved transient (150 ns) that we assign to the phenoxy radical and a shorter-lived (3-20 ns) transient
182 o the characterization of both p-substituted phenoxy radical and substituted 2-benzoylcyclohexadienon
183                        For almost 100 years, phenoxy radical coupling has been known to proceed in na
184 oxidant, effects stereoselective bimolecular phenoxy radical coupling in vitro.
185 irigent proteins impart stereoselectivity to phenoxy radical coupling reactions in plants and, thus,
186  regio- and stereospecificity of bimolecular phenoxy radical coupling reactions, of especial importan
187       These results suggest that bimolecular phenoxy radical couplings in nature can be catalyzed by
188 protein dimers, suggesting that the ROIs are phenoxy radical derivatives of the amino acid tyrosine (
189  5, while 5 reacts with 2,4,6-tri(tert-butyl)phenoxy radical in a reverse H atom transfer to generate
190 mechanism involving generation of a reactive phenoxy radical intermediate by an electron transfer pro
191  the escape of the one-electron product, the phenoxy radical leading to polymeric products.
192  selected geometry parameters, and charge on phenoxy radical oxygen q(O).
193 argeted PLPs, including the peroxidase-based phenoxy radical platform (269 +/- 41 nm) and the high-re
194                                  Evidence of phenoxy radical presence upon oxidation raises a human h
195                                Because O2(-)/phenoxy radical reactions can lead to more highly oxidiz
196 le light, the flavin photocatalyst generates phenoxy radical tags for targeted labeling.
197 let photoelectron spectroscopy bands for the phenoxy radical to generate the phenyloxenium ion 1.
198 ereoselective and regiospecific control over phenoxy radical-radical coupling appears to have evolved
199       How stereoselective monolignol-derived phenoxy radical-radical coupling reactions are different
200                                 Control over phenoxy radical-radical coupling reactions in vivo in va
201 enido dinickel(II) adduct upon addition of a phenoxy radical.
202  s(-1) and the reaction rate constant of the phenoxy radicals (k(R)) in the order of 10(9)-10(10) M(-
203 vant since recent studies have revealed that phenoxy radicals and electrophilic quinones, specificall
204 esence of methoxyl, phenoxy, and substituted phenoxy radicals as precursors for formation of major pr
205 hemistry of CDOM, we suggest that coproduced phenoxy radicals could represent a viable oxidative sink
206 ve which leads to a wide labeling radius and phenoxy radicals generated by peroxide treatment may dis
207 ling approaches based on activated esters or phenoxy radicals have been widely used for mapping subce
208 also provides evidence for the importance of phenoxy radicals produced by one-electron transfer react
209 nd located between 390 and 460 nm, while the phenoxy radicals showed two characteristic bands centere
210 itically important for oxidative coupling of phenoxy radicals to form polymers.
211                                The resulting phenoxy radicals undergo 1,5- and 1,6-hydrogen shifts in
212                      The methoxy-substituted phenoxy radicals undergo a complex series of reactions,
213 or superoxide is reaction with photoproduced phenoxy radicals within CDOM.
214 ogenation and H-atom transfer reactions with phenoxy radicals.
215 phenol radical-cations and the corresponding phenoxy radicals.
216 nt of one of the two o-methoxy groups at the phenoxy residue of the potent, but not subtype-selective
217 ogy for the depolymerization of a commercial phenoxy resin and high molecular weight hydroxylated pol
218                                              Phenoxy resin particles from the can coatings were also
219 luoroalkyl substituents at position 2 of the phenoxy ring 1-4 were synthesized.
220            The impact of substitution on the phenoxy ring and on the nitrogen atom at the 4-position
221                           Replacement of the phenoxy ring in 1 with either simple aliphatic or cycloa
222  introduction of a methoxy group in the meso-phenoxy substituent redirects the photosubstitution towa
223 ulations also highlight the ability of the 8-phenoxy substituent to lower N(7) basicity and predict a
224 d in novel PBIs (e.g., compound 14) with two phenoxy substituents specifically at the 7- and 12-bay p
225  to sixteen 4-((diethylmethylammonium)methyl)phenoxy substituents was synthesized.
226              However, those with hydroxy and phenoxy substituents were poor inhibitors of NQO1 enzyme
227            We report here the synthesis of 7-phenoxy-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazin
228  experimental corroboration suggest that the phenoxy-substituted fluorinated ketone's sp(3)-hybridize
229 hip (SAR) studies demonstrated that (i) meta-phenoxy substitution of the N-1-benzyl group is importan
230                   Importantly, electron-poor phenoxy substrates also worked well.
231 icient Rh(III)-catalyzed ortho-alkylation of phenoxy substrates with diazo compounds has been achieve
232 the characteristic ortho heterodisubstituted phenoxy substructure of 1, the S enantiomer of the dihyd
233           Synthesis of such compounds with a phenoxy tether using the 4-hydroxybenzimidazole 11 was p
234  afforded N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfona mide (PF-
235 hlorophenyl)-4-(2-fluoro-6-(trifluoromethoxy)phenoxy)thieno[2,3-d]pyrimidine (BCFTP).
236 ed at the meta- and ortho-positions of the 4-phenoxy to retain a good in vitro potency.
237 isodityrosine (3-[4'-(2-carboxy-2-aminoethyl)phenoxy]tyrosine), a non-fluorescent product of L-tyrosi
238 e dimerization of this new congener to the P-phenoxy variant are also reported, showing retention of

 
Page Top